Violent clashes erupted between Newcastle and Sunderland supporters ahead of the Tyne-Wear derby match this afternoon, with ...

How can an extension change hands with no oversight?

How to enable Advanced Protection on Android 16 - and why you shouldn't skip it ...

A buyer downsizing from a bungalow spent several months searching for a spacious condominium in either Point McKay or ...

The Hacker News is the top cybersecurity news platform, delivering real-time updates, threat intelligence, data breach ...

Merck & Co. is splitting its main pharmaceutical unit in two in an effort to better highlight the parts of the business that are growing, as it stares down a patent cliff for its best-selling cancer ...

Merck said on Monday it would split its business into two, creating ⁠a distinct division for its cancer franchise led by blockbuster drug Keytruda while grouping its non-oncology treatments separately ...

Merck to split business into oncology and non-oncology units Split does not involve its animal health division Key patents on Keytruda will begin to expire in 2028 Feb 23 (Reuters) - Merck (MRK.N), ...

Feb 23 (Reuters) - Merck said on ⁠Monday ⁠it would create a separate ⁠division for its cancer business, anchored by its top-selling drug Keytruda, as the U.S. drugmaker braces for the upcoming patent ...

Feb 23 (Reuters) – Merck said on Monday it would create a separate division for its cancer business, anchored by its top-selling drug Keytruda, as the U.S. drugmaker braces for the upcoming patent ...

Feb 23 (Reuters) - Merck is splitting its human-health business into two ‌divisions to offset pressures ‌related to the loss of patent for its top-selling drug Keytruda, the Wall Street Journal ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...